Guardian Bio
Agent33Agent Readiness: 33/100. Below median. Measured by StartupHub.ai. Median 41.Trust87Data Trust: 87/100. Top 25%. Measured by StartupHub.ai. Median 61.Biotech startup developing dendritic cell-based therapies to control immunity for cancer treatment.
About
Guardian Bio is developing a dendritic cell-based platform for cancer therapy, focused on controlling immunity using next-generation cell therapies. Co-founded in 2022 by Ananya Zutshi (BSE Duke, MS/MBA Harvard, Blavatnik Fellow) and Ricky Barrett, the YC-backed company is pioneering novel approaches to immuno-oncology. Guardian Bio has raised $500K from investors including Creative Destruction Lab, Brazen Capital, and Fundament.
Similar companies
Biotech company using genomics and AI to discover novel small-molecule medicines from microbial genomes.
Shares AI, Biotech
AI-enabled precision medicine platform using clinical and molecular data to improve patient outcomes.
Shares AI, Biotech
AI-powered technology platform improving accuracy and efficiency in pathology diagnosis and drug development research.
Shares AI, Biotech
Hugging Face is the leading AI community and platform for machine learning collaboration, enabling developers to build, share, and deploy models, datasets, and applications.
Shares AI
Chinese multinational technology company specializing in internet services and artificial intelligence.
Shares AI
Aurora Innovation develops the Aurora Driver, a self-driving system for autonomous trucks and ride-hailing vehicles.
Shares AI
Key facts
- Website
- guardian-bio.com
- Headquarters
- United States
- Founded
- 2022
- Employees
- 5
- Total funding
- $500K (Pre-Seed)
- Business model
- Biotech R&D
Tech stack
Detected on guardian-bio.com, last scanned 3 Nov 2026. Run your own scan
- Email provider
- Google Workspace
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Frequently asked
Is Guardian Bio trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Guardian Bio is 87 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Guardian Bio raised?
Guardian Bio has raised a total of $500K in funding. The most recent round on record is Pre-Seed.
How many employees does Guardian Bio have?
Guardian Bio has approximately 5 people on record.
SEC filings, insider activity, nonprofit links and pay benchmarks for Guardian Bio:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
